Expand LLY Menu
LLY MENU

LLY Stock Posts


Outlook is neutral, with stock confined to a range of ±3%

Strategy has +45% ROI potential and 16% overvalued

Outlook is neutral, with stock confined to a range of ±6%

Strategy has +51% ROI potential and 20% overvalued

Outlook is neutral, with stock confined to a channel of ±6%

Strategy has +28% ROI potential and 26% overvalued

Outlook is neutral, with stock confined to a channel of ±5%

Strategy has +42% ROI potential and 28% overvalued

Unusual Option Volume

LLY Eli Lilly And Company715.05-31.15 (-4.2%)

Eli Lilly And Company trades 27,988 contracts. The company has the following event: 66th American Society of Hematology (ASH) Annual Meeting and Exposition on Dec 8, 2024.

Outlook is neutral, with stock confined to a band of ±3%

Strategy has +38% ROI potential and 18% overvalued